Skip to main content

Multi-track investment for CordenPharma

CDMO CordenPharma is planning to invest heavily in all its platforms in terms of both capacities and capabilities, according to Dr Stephen Houldsworth, global head of platform management and marketing, who spoke with SCM at CPhI Worldwide in Milan.

In high potency, Houldsworth said, the firm has just signed off on an expansion of its development capabilities at Plankstadt in Germany. It is also expanding high potency capsule manufacture, where before Plankstadt was mostly focused on tablets, while adding hot melt extrusion to address bioavailability challenges.

Subscribe to lipid nanoparticles